Programme
Please note the programme is still subject to modifications.
Thursday, May 09, 2024
Room 1
08:00-09:30 CXR: Basic course from the Golden Age Radiologists
Moderators: N. Howarth, Chêne-Bougeries/CH; A.R. Larici, Rome/IT
Frontal view, J. Vilar Samper, Valencia/ES
Lateral view, J. Vilar Samper, Valencia/ES
Case-based CXR, T. Franquet, Barcelona/ES
09:30-10:00 Break
10:00-10:30 Coffee Break
10:30-12:00 Instructional Course on HRCT: Back to basics I
Moderators: P. Grenier, Saint Cloud/FR; J. Verschakelen, Leuven/BE
The secondary pulmonary lobule: The holy grail of thoracic imaging, H. Prosch, Vienna/AT
The nodular pattern made easy, G. Cicchetti, Rome/IT
The cystic pattern made easy, A. Oikonomou, Toronto/CA
12:00-13:00 Industry sponsored lunch symposium
13:00-13:30 Break
13:30-14:00 Opening Ceremony
A.R. Larici, Rome/IT
14:00-15:30 Lung Cancer Screening: An update
Moderator: C. Schaefer-Prokop, Amersfoort/NL; N. Sverzellati, Parma/IT
What happened in 2023 and what’s on the roadmap for 2024 and 2025?, M-P. Revel, Paris/FR
ESTI paper on definition of positive, indeterminate and negative screen, M. Silva, Parma/IT
Incidental findings: Definition and management, A. Snoeckx, Edegem/BE
AI in the era of lung cancer screening: Where are we now?, C. Jacobs, Nijmegen/NL
Perspectives for lung cancer screening with MRI, J. Biederer, Heidelberg/DE
15:30-16:30 Scientific Session 1: LCS
Moderators: M. Balbi, Turin/IT; A. Snoeckx, Edegem/BE
Patterns of lung cancer risk threshold eligibility influence LDCT outcomes and incidental findings in lung cancer screening – A single centre experience in the NHS Targeted Lung Health Check Programme, TBC
Retrospective validation and comparison of deep learning-based risk thresholds versus growth-based protocols for assessment of persisting pulmonary nodules in screening, N. Antonissen, Nijmegen/NL
Comparison of nodule segmentation algorithms in an LDCT lung cancer baseline screening dataset, Y. Mao, Groningen/NL
Assessing the agreement between privacy-preserving Llama2 model and human experts when labelling radiology reports for specific significant incidental findings in lung cancer screening, F. van der Graaf, Nijmegen/NL
Assessment of incidental findings in lung cancer screening offers potential for improved risk stratification and reduction of total low dose computed tomography burden, A. Faron, Hamburg/DE
Interstitial Lung Abnormalities (ILAs) in Italian Lung Cancer Screening Program: Prevalence and clinical-radiological correlation, C. Giannessi, Firenze/IT
Reconstruction kernels for assessment of lung parenchyma with low dose photon counting computed tomography, G. Bozovic, Lund/SE
Harnessing structured radiology reporting with clinical decision support systems to homogenise reporting in lung cancer screening, TBC
An Italian multicenter pilot study with Low-dose computed tomography for lung cancer screening integrated with smoking cessation: Preliminary baseline results, TBC
The azygos-esophageal recess is not to be missed in screening lung cancer with LDCT, D. Cozzi, Florence/IT
16:30-17:00 Coffee Break
17:00-18:30 Instructional Course: Pearls and pitfalls in imaging of thoracic emergencies
Moderators: G. Aviram, Tel Aviv/IL; L. Natale, Rome/IT
Trauma: Non vascular injury, E. Dick, London/UK
Acute Dyspnea: Edema, ARDS and differential Diagnoses, J. Biederer, Heidelberg/DE
Acute chest pain: Non cardiac causes, G. Chassagnon, Paris/FR
Room 2
08:00-09:30 Poster Presentation Session
Moderator: B.H. Heidinger, Vienna/AT
Introduction, B.H. Heidinger, Vienna/AT
Automated computed tomography airway measures to evaluate response to CFTR therapy in cystic fibrosis, G. Baxter, London/UK
Pilot review of new pathway to expedite CT following abnormal chest radiograph, J. Start, Leeds/UK
Radiation doses and Image Quality in HRCT of the lungs with Photon-Counting-CT (PCCT) expressed as CTDIvol (Computed Tomography Dose Index) or SSDE (Size Specific Dose Estimation) – Does it matter?, G. Bozovic, Lund/SE
Association between visual emphysema on CT and postoperative respiratory complications after esophagectomy, N.Y. Kim, Seoul/KR
Multicentric Magnetic Resonance Imaging of Pulmonary Abnormalities in Children with Primary Ciliary Dyskinesia, L. Wucherpfennig, Heidelberg/DE
Validation and prospective role of low-dose chest CT analysis software with Deep Learning-Based CT Slice Thickness Improvement on a 5mm slice thickness scan, J. Jeong, Seoul/KR
Sarcopenia: An Overlooked predictor of the Progression Risk in Nontuberculous Mycobacterial infections?, B. Gil, Seoul/KR
Development of an assistant system for diagnosis of pulmonary embolism, K.Y. Lee, Guro-gu/KR
Radiomic, clinical, and blood immune-inflammatory features to identify different patterns of acquired resistance in immunotherapy-treated non-small-cell lung cancer patients, C. Marrocchio, Parma/IT
Correlation between Visual Grading and AI-derived Scoring of Coronary Artery Calcification on Non-contrast Chest CT, TBC
A prediction model for pulmonary embolism from clinical and chest X-ray data, C.B. Monti, Milano/IT
Impact of multidisciplinary discussion on patients with interstitial lung disease: A 5-years hub-spoke collaboration, C. Piscitello, Siena/IT
Development and validation of a semiquantitative visual chest CT scoring system for the diagnosis of COVID-19 pneumonia: A multi-reader cross-sectional study, F. Scrocca, Rome/IT
External Validation of Deep Learning-derived Chest Radiographic Age: A Retrospective, Single-center Study, TBC
AI-Assisted Improvement in Detecting Thoracic Abnormalities on Chest Radiographs by Radiologists and Emergency Doctors, TBC
09:30-10:00 Industry sponsored slot
10:00-10:30 Coffee Break
10:30-12:00 Joint Session: ESTI/Fleischner/KSTR
Moderators: A. Parkar, Bergen/NO; J.B. Seo, Seoul/KR
The new glossary from the Fleischner Society, D. Kifjak, Vienna/AT
Updates in Lung-RADS, J.M. Goo, Seoul/KR
AI in Chest Radiograph: How to improve our clinical practice, E.J. Hwang, Seoul/KR
Post-acute COVID-19 sequelae, S.H. Yoon/KR
Trends in the incidence of pulmonary nodules in chest CT, C. Schaefer-Prokop, Amersfoort/NL
12:00-13:00 Break
13:00-13:30 Industry sponsored slot
13:30-14:00 Break
14:00-15:30 Instructional Course on HRCT: Back to basics II
Moderators: H. Prosch, Vienna/AT; C. Romei, Pisa/IT
Tackling reticular abnormalities, F. Molinari, Tourcoing/FR
Tackling chronic ground glass opacities, W. De Wever, Leuven/BE
The end game: Differential diagnosis of fibrosing lung diseases, L. Calandriello, Rome/IT
15:30-16:30 Scientific Session 2: ESTI meets KSTR
Moderator: C. Marrocchio, Parma/IT
Missed Lung Cancers in Low-dose Chest CT Lung Cancer Screening: Prevalence and Clinicoradiologic Features in South Korea, W.G. Jeong, Hwasun/KR
Evaluation of Short-Term Outcomes in a National Lung Cancer Screening Program in Korea, J.W. Lee, Bucheon/KR
Visual and Artificial Intelligence Analysis of Coronary Artery Calcification in Low-dose Chest CT Lung Cancer Screening in South Korea, W.G. Jeong, Hwasun-gun, Jeollanam-do/KR
Characteristics of ground-glass nodule in female never-smokers with a family history of lung cancer, TBC
Impact of CT Interscan Variability on Coronary Calcium Scores and Cardiovascular Risk Categorization, H. Lee, Hongseong/KR
Incidental Cardiovascular Calcifications Detected on Screening CT: Prognostic Impact over a Ten-year Follow-up, Y-H. Kim, Gwangju/KR
The Performance of artificial intelligence (AI) for the automatic quantification of coronary artery calcium (CAC) on non-contrast chest CT, TBC
Identification of the image quality of chest CT using low-concentration iodine contrast for evaluation of patients with hemoptysis: Comparison of 270 mgl/mL vs. 320 mgl/mL iodine contrast media, TBC
Interobserver Variability in Lung-RADS Categorization of Lung Cancer Screening CT: A Comparison Between a Single Tertiary Hospital and Non-tertiary Hospitals, TBC
Ultrafast scan mode of new-generation wide detector CT scanner for the evaluation of aortic root on non-gated chest CT: Comparison with five different kinds of conventional CT scanner, TBC
16:30-17:00 Coffee Break
17:00-18:30 Multidisciplinary Session: COPD
Moderators: P. Grenier, Saint Cloud/FR; M. Occhipinti, Pisa/IT
Interventional treatments for COPD: What pulmonologists need to know?, S. Gasparini, Milan/IT
COPD – The answers from radiologists, J. Verschakelen, Leuven/BE
Imaging of COPD complications, E. Van Beek, Edinburgh/UK
Friday, May 10, 2024
Room 1
07:30-08:00 ESTI General Assembly
08:00-09:30 Technical advances in CT: Just new tools or gamechangers?
Moderators: Moderators: A. Christe, Bern/CH; M. Prokop, Nijmegen/NL
Photon-counting CT, T. Frauenfelder, Zurich/CH
Upright CT, Y. Ohno, Toyoake/JP
Dual-energy CT, M. Remy-Jardin, Lille/FR
Optimal use of contrast media: How low can we go?, G. Milanese, Parma/IT
09:30-10:30 Scientific Session 3: AI & Chest
Moderators: E. Baratella, Trieste/IT; M‐P. Revel, Paris/FR
Artificial intelligence system for identification of overlooked lung metastasis in abdominal CTs of patients with malignancy, H.S. Cho, Seoul/KR
Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patients, TBC
Towards safe and reliable implementation of AI models for nodule malignancy estimation using distance-based out-of-distribution detection, D. Peeters, Nijmegen/NL
CT deep learning AI model quantified fibrosis predicts survival and treatment response in Pulmonary Hypertension associated with Chronic Pulmonary Obstructive Disease (PH-COPD), TBC
AI based automatic quantitative CT analysis for fissure completeness in Bronchoscopic Lung Volume Reduction: Comparison between CT and ChartisTM, S.M. Lee, Seoul/KR
Artificial intelligence applied to pre-admission chest x-rays: Can we entrust automated readings?, F. Rizzetto, Milan/IT
Exploring the pathological feature extraction ability of a deep learning method on X-ray images using magnetic resonance imaging as ground truth in patients with cystic fibrosis, S. Zhao, Heidelberg/DE
Automatic Classification and Decision Supporting System for Usual Interstitial Pneumonia in Chest Computed Tomography using Convolutional Neural Network, J. Jeong, Seoul/KR
Development of a machine-learning-based CT educational tool for grouping pulmonary hypertension: A proof-of-concept study, L. Cereser, Udine/IT
10:30-11:00 Coffee Break
11:00-12:00 Instructional Course: Advances in chest intervention
Moderators: S. Padley, London/UK; C.A. Ridge, London/UK
Advances in interventional maneuvers: From diagnosis …, R. Cazzato, Strasbourg/FR
Advances in interventional maneuvers: … to therapy, R. Iezzi, Rome/IT
Complications: From risk factors to management, T. Frauenfelder, Zurich/CH
12:00-12:15 Break
12:15-13:15 Industry sponsored lunch symposium
13:15-13:30 Break
13:30-14:45 Will AI make ILD easy?
Moderators: L. Calandriello, Rome/IT; A. Devaraj, London/UK
Different patterns of ILD, A. Nair, London/UK
Quantification and prognosis, J. Jacob, London/UK
AI application: What did we learn so far?, G. Chassagnon, Paris/FR
14:45-15:15 Honorary Lecture & Awarding
Moderators: J. Biederer, Heidelberg/DE; A.R. Larici, Rome/IT
The role of HRCT in ILD: Evolution from diagnosis to treatment choice, N. Sverzellati, Parma/IT
15:15-15:45 Coffee Break
15:45-17:15 Multidisciplinary Session on Lung Cancer
Moderators: T. Blum, Berlin/DE; M-P. Revel, Paris/FR
Introduction, T. Blum, Berlin/DE
The surgeon’s perspective, S. Margaritora, Rome/IT
The oncologist’s perspective, F. Passiglia, Turin/IT
The radiation oncologist’s perspective, S. Ramella, Rome/IT
The radiologist’s perspective, M.A. Sanchez Gonzalez, Barcelona/ES
Panel Discussion: “The role of the tumour board”, All speakers of the session
17:15-18:15 Image interpretation quiz (LIVE VOTING)
D. Manos, Halifax/CA; M. Radikė, Liverpool/UK
Room 2
08:00-09:30 Non-thoracic findings on routine chest CT: What to report and what not?
Moderators: R. Marano, Rome/IT; F. Molinari, Tourcoing/FR
Cardiac, R. Vliegenthart, Groningen/NL
Breast, P. Clauser, Vienna/AT
Bone and muscle, A.P. Parkar, Bergen/NO
09:30-10:30 Scientific Session 4: Not only infections
Moderator: C. De Margerie-Mellon, Paris/FR; B.H. Heidinger, Vienna/AT
Detecting Pulmonary Embolism in Non-Enhanced chest CT: Using Electron Density Maps from Dual-Energy CT, TBC
Thin-section CT findings of miliary tuberculosis and its differential diagnosis from miliary metastasis: Focusing on regional predominance of miliary nodules in terms of their size and profusion, Y.W. Choi, Seoul/KR
Clinical and Serial CT characteristics of COVID-19 pneumonia in Patients with Hematologic Malignancies Showing Persistent SARS-CoV-2 positivity, K. Beck, Seoul/KR
Evaluation of treatment response with serial CT in patients with non-tuberculous mycobacterial pulmonary disease, S. Dettmer, Hannover/DE
Radiologic findings and clinical outcomes of pulmonary nocardiosis; comparison of localized and disseminated, H. Park, Seoul/KR
CT-guided aspiration of pleural empyema and loculated pleural effusion after failed thoracic drainage, TBC
Radiomic features to predict resolved ground glass areas in COVID-19 patients after 12-month follow-up, V. Uggenti, Pisa/IT
Automated quantitative assessment of pulmonary blood volume in COVID-19 pneumonia related-pulmonary embolism: A single-center experience, C. Strappa, Rome/IT
Preliminary results of computed tomography characteristics in smear-negative pulmonary tuberculosis versus non-tuberculous mycobacterium, M.I. Azmi, Cheras/MY
Clinical and imaging features of drug-sensitive and multidrug-resistant tuberculosis: A study of Korean adults, H.S. Cho, Seoul/KR
10:30-11:00 Coffee Break
11:00-12:00 Radiomics and personalised approach to lung cancer
Moderator: A. Farchione, Rome/IT
Basic principles and technical evolution, L. Boldrini, Rome/IT
A personalised approach to lung cancer, F. Gleeson, Oxford/UK
Where are we now: Limits and challenges, M. Prokop, Nijmegen/NL
12:00-13:00 Break
13:00-13:30 Industry sponsored slot
13:30-14:45 Challenging Cases: Interactive session (LIVE VOTING)
Moderator: J. Dinkel, Munich/DE
Challenging ILD cases, C.P. Heussel, Heidelberg/DE
Challenging lung nodule cases, M-P.Revel, Paris/FR
Take home messages, J. Dinkel, Munich/DE
15:15-15:45 Coffee Break
15:45-17:15 ESTI meets ESCR
Moderators: J. Bremerich, Basel/CH; R. Vliegenthart, Groningen/NL
Imaging acute aortic syndrome, G. Aviram, Tel Aviv/IL
Imaging post-operative aorta, M. Francone, Rome/IT
Pulmonary hypertension: What role for the radiologist?, N. Screaton, Cambridge/UK
CT in the routine follow-up after heart transplantation, R. Budde, Rotterdam/NL
Saturday, May 11, 2024
Room 1
08:00-09:00 Granulomatous lung diseases (infectious and noninfectious)
Moderators: I. Hartmann, Rotterdam/NL; C. Pozzessere, Pully/CH
Tuberculosis: A new look to an old disease, E. Castañer González, Castelldefels/ES
Non tuberculous mycobacteria: A diagnostic challenge, J. Babar, Cambridgeshire/UK
Noninfectious granulomatous lung diseases, M. Both, Kiel/DE
09:00-10:00 Scientific Session 5: Chest Oncology
Moderators: G. Cicchetti, Rome/IT; T. Frauenfelder, Zurich/CH
Large cell carcinoma of the lung: LDCT features and survival in screen-detected immuno-marker undefined cases, TBC
CT patterns and clinical prognosis of radiation pneumonitis in non-small-cell lung cancer patients, H. Kang, Busan/KR
Applicability and accuracy of structured-reporting template in lung cancer staging: A comparative analysis with conventional narrative-reporting, P. Favia, Parma/IT
Enhanced Detection of Malignant Pleural Effusion in Chest CT Scans Using 40 keV Virtual Monoenergetic Images, TBC
MRI-Based Prediction Model for Assessment of Malignancy in Anterior Mediastinal Solid Tumors: Integration of Morphologic, Diffusion, and Perfusion Parameters, Y.J. Jeong, Yangsan/KR
The role of crural diaphragm density in respiratory complications after VATS lobectomy: A retrospective analysis, E. Antognoni, Ferrara/IT
CT-guided transthoracic core needle biopsies of focal pleural lesions smaller than 10 mm: A retrospective study, TBC
Predictive role of radiomic analysis in NSCLC patients treated with immunotherapy in association with ctDNA kinetics, TBC
External Validation of a Convolutional Neural Network Artificial Intelligence Tool to for the Classification of Small (≤2 cm) Pulmonary Nodules on CT Imaging, TBC
10:00-10:30 Coffee Break
10:30-12:00 ESTI meets SIRM
Moderator: C. Catalano, Rome/IT; A. Giovagnoni, Ancona/IT
Education of chest radiology in Italy, N. Sverzellati, Parma/IT
LCS in Italy, R.E. Ledda, Parma/IT
Structured reporting in fibrotic ILD, S. Palmucci, Catania/IT
Still room for chest radiograph in pulmonary disease?, E. Baratella, Trieste/IT
12:00-13:00 Industry sponsored lunch symposium
13:00-13:30 Break
13:30-15:00 9th edition of the TNM classification for thoracic cancers
Moderators: G. Milanese, Parma/IT; A. Parkar, Bergen/NO
Lung cancer staging: Updates, limitations and perspectives, H. Prosch, Vienna/AT
Staging of pleural mesotheliomas reloaded, I. Hartmann, Rotterdam/NL
Staging of thymic tumors – What is new and what do I need to know, A. Snoeckx, Edegem/BE
15:00-16:00 Thoracic Ultrasound
Moderators: L. Cardinale, Turin/IT; T. Frauenfelder, Zurich/CH
Ultrasound of the lung, M. Radzina, Riga/LV
Ultrasound of the pleura, I. Vollmer Torrubiano, Barcelona/ES
Ultrasound for thoracic intervention, C.P. Heussel, Heidelberg/DE
16:00-16:30 Coffee Break
16:30-17:30 Imaging after treatment of lung cancer
Moderators: A. Farchione, Rome/IT; B. Ghaye, Liege/BE
Drug-induced abnormalities in lung cancer patients, C. Schaefer-Prokop, Amersfoort/NL
From wedge to pneumonectomy: Imaging of surgical complications, S. Padley, London/UK
Radiotherapy for lung cancer: Recurrence or treatment effect?, A. Oikonomou, Toronto/CA
17:30-18:00 Closing and Awardings
A.R. Larici, Rome/IT; A. Parkar, Bergen/NO
Room 2
08:00-09:00 Is there something new in the ILD?
Moderator: A. Nair, London/UK; S. Palmucci, Catania/IT
Phenotyping sarcoidosis, N. Sivarasan, London/UK
ILA: Imaging prognostic marker, J.B. Seo, Seoul/KR
Progressive pulmonary fibrosis: A paradigm shift with impact on treatment, A. Devaraj, London/UK
09:00-10:00 Scientific Session 6: ILD/Airway diseases/COPD
Moderators: P‐Y. Brillet, Bobigny/FR; G. Rea, Naples/IT
Interstitial Lung Abnormalities in MRI: Detectability and Quantification Compared to CT as the Gold Standard, TBC
Quantitative evaluation of photon-counting computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor, S. Dettmer, Hannover/DE
Antisynthetase Syndrome-related-ILD: HRCT findings and quantitative analysis in a 5-year monocentric experience, L. Gozzi, Florence/IT
Quantification of the airways’ T2 MRI signal intensity in Asthma, I. Benlala, Pessac/FR
Quantitative HRCT assessment during nintedanib treatment in systemic sclerosis interstitial lung disease and idiopathic pulmonary fibrosis, V. Uggenti, Pisa/IT
CT features of interstitial lung disease associated with systemic lupus erythematosus, A. Sajust de Bergues de Escalup, Paris/FR
Estimating Respiratory Mortality in Chronic Obstructive Pulmonary Disease: Open-Source AI-based Risk Assessment Using Chest Radiographs, H. Kim, Seoul/KR
Prevalence and progression of interstitial lung abnormalities: A systematic review and meta-analysis, S. You, Suwon/KR
Quantitative CT Associate Airway Variant with Regional Lung Structure-Function Impairment in Recovery from Humidifier Disinfectant-associated Lung Injury, TBC
10:00-10:30 Coffee Break
10:30-12:00 Airway disease: From basics to advanced imaging
Moderators: J. Babar, Cambridgeshire/UK; F. Gleeson, Oxford/UK
Imaging of the trachea and proximal airways, P-Y. Brillet, Bobigny/FR
Imaging bronchiectasis: What’s new, M. Prokop, Nijmegen/NL
Qualitative and quantitative CT assessment of COPD, M. Occhipinti, Pisa/IT
MRI for the assessment of patients with COPD, J. Biederer, Heidelberg/DE
12:00-13:00 Break
13:00-13:30 ILA: What’s new?
Moderators: A.R. Larici, Rome/IT; L. Richeldi, Rome/IT
Pitfalls in nodule management, A. Kerpel-Fronius, Budapest/HU
Lung cancer staging – Tips and tricks, M. Silva, Parma/IT
Interstitial lung diseases – Not what it seems, C. Ridge, London/UK
13:30-15:00 Not only Infections
Moderators: E. Castañer González, Castelldefels/ES; R. Polverosi, Padua/IT
Infectious diseases in immunocompromised patients, T. Franquet, Barcelona/ES
CAP – Community acquired pneumonias, C. De Margerie-Mellon, Paris/FR
The many faces of pulmonary aspiration, T. Franquet, Barcelona/ES
15:00-16:00 Instructional Course: Pitfalls in thoracic imaging (LIVE VOTING)
Moderator: C. Schaefer-Prokop, Amersfoort/NL
Pitfalls in nodule management, A. Kerpel-Fronius, Budapest/HU
Lung cancer staging – Tips and tricks, M. Silva, Parma/IT
Interstitial lung diseases – Not what it seems, C.A. Ridge, London/UK
16:00-16:30 Coffee Break
16:30-17:30 Multidisciplinary Session on ILD
Moderators: N. Sverzellati, Parma/IT; C. Vancheri, Catania/IT
Treatment of ILD in a nutshell, L. Richeldi, Rome/IT
New diagnostic biomarkers for UIP, A. Unterman, Tel Aviv/IL
Acute Lung Injury and the development of the NSIP and UIP patterns of fibrosis, S. Kligerman, Denver/US